The FDA will work to expedite the development and review of the drug so it can get to patients as soon as possible.
The metabolism of psilocybin and psilocin is often cited. But, the supporting data are seldom discussed.
Psilocybin is showing promise for neuroregeneration and motor recovery in methods of treating phantom pain.
Recent studies on the biosynthesis of psilocybin provide an answer to this age-old question.
Researchers measured the effects of psilocybin in depressed people by comparing brain scan data.
New research examines the association between lifetime psychedelic use and intimate partner violence.